Regen BioPharma, Inc.
RGBP · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$867 | $1,157 | $2,444 | -$6,765 |
| Dep. & Amort. | $29 | $0 | $71 | $51 |
| Deferred Tax | $0 | -$255 | -$46 | -$51 |
| Stock-Based Comp. | $6 | $348 | $46 | $0 |
| Change in WC | $0 | -$1,929 | -$3,137 | $4,450 |
| Other Non-Cash | $139 | $505 | $16 | $1,184 |
| Operating Cash Flow | -$693 | -$174 | -$607 | -$1,131 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $25 | $495 |
| Other Inv. Act. | $0 | $0 | $25 | $495 |
| Investing Cash Flow | $0 | $0 | $25 | $495 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$95 | $0 |
| Stock Issued | $146 | $250 | $46 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $573 | $244 | $0 | $1,363 |
| Financing Cash Flow | $573 | $244 | -$94 | $1,363 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$120 | $70 | -$676 | $727 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $121 | $51 | $727 | $0 |
| End Cash | $1 | $121 | $51 | $727 |
| Free Cash Flow | -$693 | -$174 | -$607 | -$1,131 |